Report

Big Data as a Service Market Report 2022-2027, Industry Share, Size, Growth, Trends and Opportunities

on
0

Vaccine Market 2021-2026: Size, Price, Growth, Share, Covid-19 Impact, Outlook, and Forecast

on

According to the latest report by IMARC Group, titled “Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the global vaccine market size reached US$ 41.4 Billion in 2020. On account of the aforementioned factors, the market is anticipated to grow at a CAGR of 8.2% during 2021-2026. 

A vaccine stands for a biological component that stimulates antibody production against harmful pathogens in the body. It is typically produced by using disease-causing agents and chemical drugs acting as antigens for preventing diseases. Vaccines are mainly available as inactivated, conjugate, live attenuated, recombinant, and toxoid vaccines. They protect the body against a wide range of various life-threatening diseases, including polio, measles, diphtheria, meningitis, tetanus, etc. As a result, vaccines find widespread applications in several immunization procedures across numerous healthcare facilities and for research purposes in academic and clinical laboratories.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request Free Sample Report: https://www.imarcgroup.com/vaccine-market/requestsample

Global Vaccine Market Trends and Drivers:

The increasing prevalence of several infectious diseases is one of the primary factors driving the market for vaccines. Moreover, the growing consumer awareness towards effective immunization for eradicating various infections is further augmenting the product demand. Additionally, the introduction of vaccination programs by government bodies across numerous endemic regions is further propelling the market growth. Furthermore, several global organizations, such as the WHO, UNICEF, Bill & Melinda Gates Foundation, etc., are launching adequate vaccination facilities across the developing and under-developed countries. Apart from this, the outbreak of the COVID-19 pandemic, since early 2020, has led to the development of novel vaccines to combat the risk of coronavirus infection. This is expected to further catalyze the growth of the global vaccine market in the coming years.

Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/vaccine-market

Key Market Segmentation:       

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

  • Abbott Laboratories
  • Astellas Pharma Inc.
  • AstraZeneca Plc
  • Bharat Biotech International Limited
  • Bavarian Nordic A/S
  • CSL Limited
  • Daiichi Sankyo Company, Limited
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline Plc
  • Inovio Pharmaceuticals Inc.
  • Johnson & Johnson, Inc.
  • Merck & Co. Inc.
  • Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Holdings Corporation)
  • Novavax Inc.
  • Panacea Biotec Ltd.
  • Pfizer Inc.
  • Sanofi Pasteur SA (Sanofi SA)
  • Serum Institute of India Pvt. Ltd.
  • Takeda Pharmaceutical Company Limited

Breakup by Technology:

  • Conjugate Vaccines
  • Inactivated and Subunit Vaccines
  • Live Attenuated Vaccines
  • Recombinant Vaccines
  • Toxoid Vaccines
  • Others

Breakup by Patient Type:

  • Paediatric
  • Adult

Breakup by Indication:

  • Bacterial Diseases
    • Meningococcal Disease
    • Pneumococcal Disease
    • Diphtheria/Tetanus/Pertussis (DPT)
    • Tuberculosis
    • Haemophilus Influenzae (Hib)
    • Typhoid
    • Others
  • Viral Diseases
    • Hepatitis
    • Influenza
    • Human Papillomavirus (HPV)
    • Measles/Mumps/Rubella (MMR)
    • Rotavirus
    • Herpes Zoster
    • Varicella
    • Japanese Encephalitis
    • Rubella
    • Polio
    • Rabies
    • Dengue
    • Others

Breakup by Route of Administration:

  • Intramuscular and Subcutaneous Administration
  • Oral Administration
  • Others

Breakup by Product Type:

  • Multivalent Vaccine
  • Monovalent Vaccine

Breakup by Treatment Type:

  • Preventive Vaccine
  • Therapeutic Vaccine

Breakup by End User:

  • Hospitals
  • Clinics
  • Vaccination Centres
  • Academic and Research Institutes
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Institutional Sales
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the Report:

  • Market Performance (2015-2020)
  • Market Outlook (2021-2026)
  • COVID-19 Impact on the Market
  • Porter’s Five Forces Analysis
  • Historical, Current and Future Market Trends
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Structure of the Market
  • Value Chain Analysis
  • Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group       
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Latest Market Research Reports by IMARC Group (2021-2026):

Comments

Post a Comment